Providers Don Downing Clinical Professor Univ of WA School of Pharmacy Seattle WA dondownuwedu Conflicts of Interest I have no commercial conflicts of interest and I am not being compensated for this webinar ID: 736210
Download Presentation The PPT/PDF document "Pharmacists as Medical" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Pharmacists as Medical Providers
Don Downing
Clinical Professor, Univ. of WA School of Pharmacy
Seattle, WA
dondown@uw.eduSlide2
Conflicts of InterestI have no commercial conflicts of interest and I am not being compensated for this webinar
I am not a consultant or advisor for Wolters Kluwer Clinical Drug InformationSlide3
ObjectivesUnderstanding the difference between pharmacist provider status & pharmacist medical provider status
Creating provider leverage from existing state laws
Establishing professional guidelines when both prescribing & selling prescription medications
Unbundling pharmacy location licenses from pharmacist medical provider practice
Establishing sustainable & responsible professional practices that improve patient outcomesSlide4
What is Provider Status?Slide5
Provider StatusWhat is it that pharmacists are seeking? Is it…
Professional, patient & legislative recognition of our clinical skills & services?
A scope of practice expansion, incl. prescribing medications?
Elimination of dependence on selling medications for income?
A new revenue stream that compensates & sustains professional practice?
“Full” membership on healthcare teams / medical boards?
Getting out of the “drug benefit” wedge?
A legislative acknowledgement that says pharmacists are providers?
Ability to practice at the top of our license
To be able to help patients in ways we struggle to provide right nowSlide6
Pharmacist provider statusState legislative recognition in name only
No Federal recognition other than low-level MTM billings by pharmacies (but not pharmacists)
Payment of some services through NDC#-based claims submissions
Payment of some services through “incident-to” medical billings
Facility fee payments for health system clinical care services
But: mostly provision of valuable clinical services without sustainable compensation due to rejection of pharmacists as contracted, credentialed providers in health plan networksSlide7
Pharmacist medical provider status
State and commercial health plans recognize pharmacists as contracted and credentialed medical providers (Feds soon…?)
Major medical CPT and ICD-10 codes used for provider claims
Incident-to billing the exception rather than the rule
Pharmacists making decisions not just taking orders
Collaborative agreements are not direct supervision by physicians – they are coordination of care / expansion of care partnerships
No PBM involvement
Allows clinics, hospitals and community pharmacies to hire pharmacists as medical providers – not pharmacist providersSlide8
Getting there: Where is the Leverage?Slide9
Creating leverage for pharmacist medical provider status
Searching state laws
Every Category of Provider Laws (not the same as Any Willing Provider Laws)
Anti-discrimination laws
These laws may make it illegal for health plans and Insurance Commissioners to deny pharmacists from contracting as medical providers
May need to get a State Attorney General’s opinion to prove your point
Patient advocacy organizations
They are struggling to find patient access to care
They speak with a larger and louder voice than pharmacists
They need and want pharmacists to help their clients
Engaging the “Treating” docs more than “Meeting” docsSlide10
Conflicts of InterestSlide11
Conflicts of Interest GuidelinesA common pushback for pharmacist medical provider status for ambulatory care and community pharmacists is the perceived or real conflicts of interest involved when a pharmacist both makes the therapeutic drug choices and also dispenses these medications.
Case: Pharmacist in community pharmacy is providing lipid management services and commonly treats patients with an inexpensive generic statin. Pressure comes from pharmacy management to improve prescription profits by asking clinical pharmacist to move these patients to another statin than has a larger profit margin.Slide12
Conflicts of Interest Guidelines
Issues:
Pharmacy has argued that physicians should not sell the
Rxs
they prescribe
A pharmacist medical provider is subject to pressure that may not be in their patients’ best interest
Urgent prevention-based pharmacist prescribing may not fall under the same conflict of interest (i.e. naloxone,
ella
™, epinephrine, vaccines, etc.)
You do not want to defend yourself in front of a news camera when a reporter asks you if you are prescribing in the full interest of a patient or in the interest of your pharmacy prescription business.
Is there a need for a state conflict of interest guideline?
P
harmacy should own that guideline before they are forced to defend their dual role of prescribing and dispensing.Slide13
Pharmacy Location LicensureSlide14
Mandated Pharmacy Location licensure
Most states have laws/rules that require pharmacists to practice in a licensed pharmacy
Should a pharmacist medical provider who is not dispensing medications be required to get a pharmacy location license?
If you are seeking pharmacist medical provider status, consider amending your state pharmacy regulations or get a legal opinion regarding the need for a location license as soon as possible.Slide15
A Brave New WorldSlide16
Pharmacist medical provider:Rules of the road
Issues to ponder:
Are you’re a specialist, a primary care provider or both in health plan networks?
Does your compensation reasonably match the value you provide and your ability to provide sustainable clinical services?
When do your clinical services need a prior referral or other similar mechanism in order to meet quality assurance requirements to: coordinate care, to not duplicate care, & to provide medically necessary services?Slide17
Rules of the RoadWho will credential you with employers and health plans?
Does
your employer have a “delegated credentialing” contract with health plans?
What is your scope of practice and how is that decided?
What CPT/ICD-10 billing codes will you insist be appropriate for your services?
Are you measuring outcomes?Slide18
Rules of the Road: Collaborative Agreements
It’s time to look at your collaborative drug therapy management agreement (CDTA) regulations:
Do CDTA regulations only allow pharmacists to implement, modify or discontinue drug therapy when the authorizing physician has a legitimate physician-patient relationship?
What about patients who don’t have a physician provider? Shouldn’t you as a “medical provider” be their initial provider?
Can only physicians sign CDTAs?
Are CDTA relationships with physicians a direct supervisory relationship?
Are pharmacists writing prescriptions or furnishing /dispensing prescriptions under protocol?Slide19
Pharmacist medical provider status
Will your state pharmacist association, your state medical association, your state legislature, or your state’s health plans decide that pharmacist medical providers need to achieve a higher pharmacy practice status in order to provide and be compensated for pharmacist medical provider services?
Is a pharmacy degree adequate?
Do you need to complete a residency?
Do you need Board Certification?
Are these requirements barriers to patient access to care?
Can schools of pharmacy graduate students who are prequalified to be pharmacist medical providers?
States are answering these questions differently. Carefully consider the consequences.Slide20
Questions?